Latest On PT Kalbe Farma Tbk (PTKFF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-12 06:04 EST | Dividend | A dividend of $38 has been announced on May 8, 2023. It will be paid May 31, 2023 with an ex-dividend date of May 12, 2023. | Neutral |  |
| 2022-06-01 06:02 EST | Dividend | A dividend of $35 has been announced on May 27, 2022. It will be paid Jun 22, 2022 with an ex-dividend date of Jun 1, 2022. | Neutral | |
| 2021-06-08 06:11 EST | Dividend | A dividend of $28 has been announced on Jun 2, 2021. It will be paid Jun 30, 2021 with an ex-dividend date of Jun 8, 2021. | Neutral | |
| 2020-12-04 05:06 EST | Dividend | A dividend of $6 has been announced on Nov 27, 2020. It will be paid Dec 18, 2020 with an ex-dividend date of Dec 4, 2020. | Neutral | |
| 2020-07-29 10:38 EST | Stock Split | A stock split has occured on Oct 8, 2012 with a split factor of 5:1. | Neutral | |
| 2020-07-28 17:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 15:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 20:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 11:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 19:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 15:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 07:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-02 06:07 EST | Dividend | A dividend of $20 has been announced on May 20, 2020. It will be paid Jun 19, 2020 with an ex-dividend date of Jun 2, 2020. | Neutral | |
| 2020-05-27 07:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 03:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-09 22:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 08:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 03:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-02 22:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 18:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-26 10:27 EST | Stock Split | A stock split has occured on Oct 8, 2012 with a split factor of 5:1. | Neutral | |
| 2020-04-20 06:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-09 22:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-08 18:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 23:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-25 22:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-14 22:26 EST | Stock Split | A stock split has occured on Oct 8, 2012 with a split factor of 5:1. | Neutral | |
| 2020-02-28 06:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 00:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-22 01:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-21 01:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-18 01:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-15 01:16 EST | News | Kalbe Farma: Regulatory Headwinds Responsible For Valuation Derating | N/A | |
| 2020-02-14 13:02 EST | Earnings | Earnings have been released on December 31, 2014, with $0.00 earnings per share. | Buy | |
| 2020-02-14 13:02 EST | Earnings | Earnings have been released on September 30, 2014, with $0.00 earnings per share. | Buy | |
| 2020-02-14 13:02 EST | Earnings | Earnings have been released on June 30, 2014, with $0.00 earnings per share. | Buy | |
| 2020-02-14 13:02 EST | Earnings | Earnings have been released on September 30, 2015, with $0.00 earnings per share. | Buy | |
| 2020-02-14 13:02 EST | Earnings | Earnings have been released on June 30, 2015, with $0.00 earnings per share. | Buy | |
| 2020-02-14 13:02 EST | Earnings | Earnings have been released on March 31, 2015, with $0.00 earnings per share. | Buy | |
| 2020-02-14 13:02 EST | Earnings | Earnings have been released on June 30, 2016, with $0.00 earnings per share. | Buy | |
| 2020-02-14 13:02 EST | Earnings | Earnings have been released on March 31, 2016, with $0.00 earnings per share. | Buy | |
| 2020-02-14 13:02 EST | Earnings | Earnings have been released on December 31, 2015, with $0.00 earnings per share. | Buy | |
| 2020-02-14 13:02 EST | Earnings | Earnings have been released on December 31, 2016, with $0.00 earnings per share. | Buy | |
| 2020-02-14 13:02 EST | Earnings | Earnings have been released on September 30, 2016, with $0.00 earnings per share. | Buy | |
| 2020-02-14 13:02 EST | Earnings | Earnings have been released on September 30, 2017, with $0.00 earnings per share. | Buy | |
| 2020-02-14 13:02 EST | Earnings | Earnings have been released on June 30, 2017, with $0.00 earnings per share. | Buy | |
| 2020-02-14 13:02 EST | Earnings | Earnings have been released on March 31, 2017, with $0.00 earnings per share. | Buy | |
| 2020-02-14 13:02 EST | Earnings | Earnings have been released on June 30, 2018, with $0.00 earnings per share. | Buy | |
About PT Kalbe Farma Tbk (PTKFF):
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. It operates in four segments: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The company offers generic, branded, and licensed drugs, including Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG that are distributed to hospitals, pharmacies, and drug stores. It also provides over-the-counter drugs; energy drinks, ready-to-drink products, supplements, and other preventive products; and nutritional products for infants, toddlers, children, pre-teenagers, adults, pregnant and lactating women, and elders, as well as for consumers with special medical needs. In addition, the company operates Mitrasana Clinics, a health care service; contract services, including clinical study management, bioavailability/bioequivalence studies, and contract analysis to pharmaceutical companies; and animal health products. Further, it offers health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as provides advertising services. The company was founded in 1966 and is headquartered in Jakarta, Indonesia. PT Kalbe Farma Tbk. is a subsidiary of PT Gira Sole Prima.
General
- Name PT Kalbe Farma Tbk
- Symbol PTKFF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers—General
- Full Time Employees 12,427
- Last Split Factor5:1
- Last Split Date2012-10-08
- Fiscal Year EndDecember
- Web URLhttp://www.kalbe.co.id
View More
Valuation
- Trailing PE 26.77
- Forward PE 26.04
- Price/Sales (Trailing 12 Mt.) 3
- Price/Book (Most Recent Quarter) 4.2
View More
Financials
- Most Recent Quarter 2020-03-31
- Profit Margin 11%
- Return on Assets 10%
- Return on Equity 16%
- Revenue Per Share $0
- Gross Profit 10.07 trillion
- Quarterly Earnings Growth 8%
View More
Highlights
- Market Capitalization 49.58 billion
View More
Share Statistics
- Shares Outstanding 46.88 billion
- Shares Float 20.01 billion
- % Held by Insiders 5730%
- % Held by Institutions 12.36%
View More
Technicals
- Beta 0.66
- 52 Week High $0.15
- 52 Week Low $0.01
- 50 Day Moving Average 0.1
- 200 Day Moving Average 0.1
View More
Dividends
- Forward Annual Dividend Yield 2.29%
- Payout Ratio 47%
- Dividend Date 2017-07-07
- ExDividend Date 2019-06-10
- Dividend Per Share $N/A
- Dividend Yield 0%
View More
PT Kalbe Farma Tbk (PTKFF) Dividend Calendar:
PTKFF's last dividend payment was made to shareholders on July 7, 2017.
PT Kalbe Farma Tbk pays out 47% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
PT Kalbe Farma Tbk (PTKFF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-03-31 | 2020-04-01 | $5.8 trillion | $12.62 | $15.40 | -18.05% |
| 2019-12-31 | 2019-12-31 | $5.81 trillion | $0.00 | ||
| 2019-09-30 | 2019-11-01 | $5.65 trillion | $14.02 | $14.40 | -2.64% |
| 2019-06-30 | 2019-07-31 | $5.81 trillion | $14.15 | $14.70 | -3.74% |
| 2019-03-31 | 2019-04-30 | $5.37 trillion | $12.69 | $13.06 | -2.83% |
| 2018-12-31 | 2019-03-29 | $5.4 trillion | $13.93 | $14.10 | -1.21% |
| 2018-09-30 | 2018-10-30 | $5.3 trillion | $12.55 | $12.82 | -2.11% |
| 2018-06-30 | 2018-08-22 | $5.37 trillion | $13.37 | $14.15 | -5.51% |
| 2018-03-31 | 2018-04-30 | $5.01 trillion | $12.57 | $13.36 | -5.91% |
| 2017-12-31 | 2018-03-28 | $5.09 trillion | $13.32 | $13.70 | -2.77% |
| 2017-09-30 | 2017-10-31 | $5.02 trillion | $12.01 | $13.00 | -7.62% |
| 2017-06-30 | 2017-07-31 | $5.17 trillion | $13.40 | $13.82 | -3.04% |
| 2017-03-31 | 2017-04-28 | $4.9 trillion | $12.55 | $13.20 | -4.92% |
| 2016-12-31 | 2017-03-31 | $5 trillion | $12.74 | $13.92 | -8.48% |
| 2016-09-30 | 2016-10-31 | $11.87 | $10.78 | 10.11% | |
| 2016-06-30 | 2016-07-29 | $0.00 | |||
| 2016-03-31 | 2016-04-29 | $12.02 | $12.20 | -1.48% | |
| 2015-12-31 | 2016-02-26 | $10.76 | $10.09 | 6.64% | |
| 2015-09-30 | 2015-10-30 | $9.30 | $11.10 | -16.22% | |
| 2015-06-30 | 2015-07-31 | $12.00 | $12.13 | -1.07% | |
| 2015-03-31 | 2015-04-30 | $0.00 | |||
| 2014-12-31 | 2015-03-30 | $0.00 | $11.76 | -99.99% | |
| 2014-09-30 | 2014-11-05 | $0.00 | |||
| 2014-06-30 | 2014-06-30 | $0.00 |
PT Kalbe Farma Tbk (PTKFF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 |
|---|---|---|---|---|---|
| Research Development | 67.56 billion | 305.07 billion | 65.92 billion | 71.24 billion | 61.25 billion |
| Income Before Tax | 887.56 billion | 828.35 billion | 889.04 billion | 903.43 billion | 803.41 billion |
| Selling General Administrative | 996.66 billion | 843.06 billion | 1.62 trillion | 1.7 trillion | 1.63 trillion |
| Gross Profit | 2.62 trillion | 2.48 trillion | 2.55 trillion | 2.63 trillion | 2.46 trillion |
| Ebit | 980 billion | 886.01 billion | 880.01 billion | 868.25 billion | 773.19 billion |
| Operating Income | 816.4 billion | 850.79 billion | 880.01 billion | 868.25 billion | 773.19 billion |
| Income Tax Expense | N/A | 242.04 billion | 221.65 billion | 228.6 billion | 199.8 billion |
| Total Revenue | 5.8 trillion | 5.81 trillion | 5.65 trillion | 5.81 trillion | 5.37 trillion |
| Cost of Revenue | 3.18 trillion | 3.33 trillion | 3.1 trillion | 3.18 trillion | 2.91 trillion |
| Total Other Income Expense Net | N/A | N/A | 9.03 billion | 35.18 billion | 30.22 billion |
| Net Income From Continuing Operations | 677.03 billion | 591.77 billion | 667.39 billion | 674.83 billion | 603.61 billion |
| Net Income Applicable to Common Shares | N/A | 591.3 billion | 657.3 billion | 663.1 billion | 595.07 billion |
Cash Flow:
| Date | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 |
|---|---|---|---|---|---|
| Investments | -342.02 billion | -559.46 billion | N/A | -2.13 billion | -2.13 billion |
| Change to Liabilities | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Investing Activities | N/A | -559.46 billion | -473.18 billion | -464.93 billion | -402.98 billion |
| Net Borrowings | N/A | 42.89 billion | -1.4 billion | 234.52 billion | 139.96 billion |
| Total Cash Flow from Financial Activities | N/A | N/A | -50.64 billion | -827.51 billion | 133.8 billion |
| Change to Operating Activities | N/A | N/A | N/A | N/A | N/A |
| Change in Cash | 675.55 billion | 424.57 billion | 143.72 billion | -728.42 billion | 40.35 billion |
| Total Cash from Operating Activities | N/A | 946.59 billion | 669.2 billion | 566.79 billion | 320.39 billion |
| Depreciation | N/A | N/A | 120.13 billion | 118.29 billion | 112.73 billion |
| Other Cash Flow from Investing Activities | N/A | 15.36 billion | 20.45 billion | 36.32 billion | 32.1 billion |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | N/A | -5.45 billion | 132.13 billion | -24.65 billion | -6.17 billion |
| Change to Net Income | N/A | 225.58 billion | -117.54 billion | -224.63 billion | -396.99 billion |
| Capital Expenditures | 373 billion | 546.31 billion | 448.65 billion | 485.87 billion | 426.2 billion |
Balance Sheet:
| Date | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 4.88 trillion | 3.56 trillion | 3.46 trillion | 3.52 trillion | 3.32 trillion |
| Total Stockholder Equity | 16.44 trillion | 15.89 trillion | 15.32 trillion | 14.66 trillion | 15.22 trillion |
| Other Current Liabilities | N/A | N/A | 626.39 billion | 786.83 billion | 840.71 billion |
| Total Assets | 22.13 trillion | 20.26 trillion | 19.59 trillion | 18.81 trillion | 19.18 trillion |
| Common Stock | N/A | 468.75 billion | 468.75 billion | 468.75 billion | 468.75 billion |
| Other Current Assets | 296.44 billion | 55.16 billion | 229.24 billion | 244.94 billion | 244.04 billion |
| Retained Earnings | 15.58 trillion | 15.14 trillion | 14.77 trillion | 14.11 trillion | 14.67 trillion |
| Other Liabilities | N/A | 334.35 billion | 311.99 billion | 316.35 billion | 311.41 billion |
| Other Assets | N/A | 622.3 billion | 598.66 billion | 661.26 billion | 661.94 billion |
| Cash | 3.93 trillion | 3.04 trillion | 2.61 trillion | 2.48 trillion | 3.2 trillion |
| Total Current Liabilities | 3.85 trillion | 2.58 trillion | 2.55 trillion | 2.66 trillion | 2.65 trillion |
| Other Stockholder Equity | N/A | 63.25 billion | 84.29 billion | 83.62 billion | 81.92 billion |
| Property, Plant & Equipment | N/A | 7.67 trillion | 7.33 trillion | 6.95 trillion | 6.67 trillion |
| Total Current Assets | 12.67 trillion | 11.22 trillion | 11.08 trillion | 10.66 trillion | 11.33 trillion |
| Long Term Investments | N/A | N/A | 87.61 billion | 89.51 billion | 85.22 billion |
| Net Tangible Assets | N/A | 15.23 trillion | 14.83 trillion | 14.22 trillion | 14.78 trillion |
| Short Term Investments | 199.35 billion | 195.62 billion | 191.9 billion | 187.56 billion | 183.83 billion |
| Long Term Debt | 629.33 billion | 647.65 billion | 594.13 billion | 541.36 billion | 356.63 billion |
| Inventory | 3.68 trillion | 3.74 trillion | 3.89 trillion | 3.7 trillion | 3.75 trillion |
| Accounts Payable | 1.41 trillion | 1.22 trillion | 1.27 trillion | 1.22 trillion | 1.24 trillion |
PT Kalbe Farma Tbk (PTKFF) Chart:
PT Kalbe Farma Tbk (PTKFF) News:
Below you will find a list of latest news for PT Kalbe Farma Tbk (PTKFF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
PT Kalbe Farma Tbk (PTKFF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
PT Kalbe Farma Tbk (PTKFF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|